Details of the Drug Reposition

General Information of This Drug (ID: DMP4519)

• Drug Name: RSLV-132 (DMP4519)

Information on Drug Reposition of This Drug

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Systemic lupus erythematosus	DISI1SZ7	4A40.0	Phase 2	[1]
Sjogren syndrome	DISUBX7H	4A43.20	Phase 2	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)